We utilized a heterozygous, conditional knockout of Bdnf on allele using the Cre/loxP system, as BDNF is reduced in participants with schizophrenia, and increasing protein levels may have beneficial clinical outcomes [30]. The gene discussed is BDNF; the disease is schizophrenia.